Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia

N Engl J Med. 2023 Mar 9;388(10):952-954. doi: 10.1056/NEJMc2216135.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols
  • Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
  • Humans
  • Leukemia, Hairy Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Sulfonamides* / therapeutic use

Substances

  • Antineoplastic Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • venetoclax